Oregon

In Review: The legislature adjourned sine die on Friday, June 27. In the meantime, the Oregon State Pharmacy Association (OSPA) sent a letter to the state’s Prescription Drug Affordability Board (PDAB) urging them to ban PBMs from operating in the state. Putting

In Review: House Bill 3212 (spread pricing, reimbursement, refuse to fill, balance billing patients) is still technically alive as it sits in the Assembly Rules Committee. However, we have been told that it will not advance this session. We also

In Review: Following last week’s Behavioral Health and Health Care Committee’s informational hearing on HB 3212 (spread pricing, reimbursement, refuse to fill), Chair Rob Nosse (D) has asked the Rules Committee to advance the bill. This is despite his earlier

Up Next: Behavioral Health and Health Care Committee Chair Rob Nosse (D) has called for an informational hearing today, May 27, to discuss whether there is any possibility to find agreement on HB 3212 (spread pricing, reimbursement, refuse to fill). The bill

In Review: Last week, the House Behavioral Health and Health Care Committee moved both HB 3212 (spread pricing, reimbursement, refuse to fill) and HB 219 (PSAO licensure) to the House Rules Committee without a recommendation. This was done to move the

In Review: The pharmacists canceled the last stakeholder meeting. PBMs and plans used the time to share our final redline version of HB 3212 (spread, reimbursement, preferred network participation, refuse to fill) with Representatives Ed Diehl (R) and Emily McIntire

In Review: Last week, the Department of Consumer and Business Services (DCBS) issued an analysis of using NADAC as the basis for commercial pharmacy reimbursement would violate Oregon State Constitution under its non-delegation clause. As a result, DCBS would need to

In Review: Representatives Ed Diehl (R) and Emily McIntire (R) called the first HB 3212 (ban on spread pricing and dispensing fees) stakeholder meeting on Wednesday, February 12. However, we only heard about the meeting four hours before it was

In Review: The House Behavioral Health and Health Care Committee heard several PBM bills last week, February 4, including HB 3212 (ban on spread pricing, AWP, and minimum pharmacy fees). Both sides were able to present for roughly 30 minutes